accountaccording to results of late-stage study reported Monday. More from Adam Feuerstein Market Activity Amarin Corporation PLC| AMRN GlaxoSmithKline PLC| GSK Amarin said AMR101 met all the efficacy and safety endpoints in the phase III study and as a result,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Amarin: Fish-Oil Pill Delivers Strong Results
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account